Pharmaceutical Executive May 11, 2021
Amgen is collaborating on two digital health initiatives aimed at improving heart failure care and rehabilitation.
With gaps in the use and dosing of medication and the increasing complexity of treatment, e.g., the requirement for multiple medications and lifestyle changes, Amgen is steering two digital health initiatives to address the failings of “traditional” approaches to the treatment and rehabilitation around heart failure and heart attacks. In the US, the Amgen congestive heart failure (CHF) study will compare guideline-directed CHF therapy that uses digital health data with traditional practices that do not, while in Europe the company is involved in the creation of a digital “tele-rehabilitation solution” to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a...
Today's Sponsors
Today's Sponsor